Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
0.6640
-0.1003 (-13.12%)
At close: Jul 31, 2026, 4:00 PM EDT
0.6821
+0.0181 (2.73%)
Pre-market: Aug 3, 2026, 5:53 AM EDT

CELZ Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.010.010.010.090.09
Revenue Growth
-78.57%-45.45%22.22%-89.84%0.96%-46.65%
Gross Profit
000.010.010.060.04
Operating Income
-5.94-6.14-5.74-5.62-10.24-3.13
Net Income
-5.76-6-5.49-5.29-10.1419.21
Earnings Per Share
-2.14-2.52-3.71-3.76-9.2856.10
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5.857.215.949.9918.410.72
Total Debt
0.010.010.010.010.010.01
Net Cash (Debt)
5.837.195.939.9718.3810.71
Net Cash Growth
-24.12%21.39%-40.58%-45.76%71.67%-
Net Cash Per Share
2.023.024.007.0816.8232.97

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.59-5.86-5.3-8.03-7.8-2.22
Free Cash Flow
-5.59-5.86-5.3-8.03-7.8-2.22
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.87%63.43%60.00%60.00%67.84%45.36%
Operating Margin
-198050.00%-102380.00%-52216.90%-62445.90%-11562.50%-3562.17%
Pretax Margin
-192020.93%-99916.80%-49940.74%-58739.71%-11449.26%21892.75%
Profit Margin
-192021.00%-99916.80%-49940.70%-58739.70%-11449.30%21892.80%
FCF Margin
-186274.00%-97607.40%-48193.60%-89198.70%-8800.19%-2524.99%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----0.39
PS Ratio
818.201207.58367.17703.6060.53159.64